Titan Medical Inc. Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Patent Rights (Tables)

9 Months Ended

Sep. 30, 2019


For the nine months ended September 30, 2019	Cost		Accumulated Amortization & Impairment Losses			Net Book Value
Balance at December 31, 2018	$	1,398,713	$	(226,228	)	$	1,172,485
Additions during the period		347,646		—			347,646
Amortization in the period		—		(20,766	)		(20,766	)

Balance at September 30, 2019	$	1,746,359	$	(246,994	)	$	1,499,365